{"id":34879,"date":"2018-08-24T15:27:06","date_gmt":"2018-08-24T15:27:06","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=34879"},"modified":"2018-08-24T17:18:46","modified_gmt":"2018-08-24T17:18:46","slug":"24-august-2018-vol-19-no-14-aids-2018-next-reports","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/34879","title":{"rendered":"24 August 2018: vol 19 no 14: AIDS 2018 \u2013 next reports&#8230;"},"content":{"rendered":"<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/date\/2018\/08\/24\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-34884\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2018\/08\/HTB-24-Aug-2018-cover-210x300.png\" alt=\"\" width=\"210\" height=\"300\" \/>Contents online<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2018\/08\/HTB-24-Aug-2018-no-14-2-column.pdf\" rel=\"noopener\">PDF of this issue<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/forms\/esub.php\">Subscribe by email<\/a><\/li>\n<\/ul>\n<p><strong>This issue of HTB continues our reports from the 22nd International AIDS Conference (AIDS 2018) that was held from 23\u201327 July 2018 in Amsterdam.<span class=\"Apple-converted-space\">\u00a0<\/span><\/strong><\/p>\n<p>We start with the optimistic news that Namibia is already close to achieving the 90-90-90 goals \u2013 with results presented by the Namibian Minister of Health at the conference.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p>Less optimistically, two studies showed results from using dolutegravir monotherapy, which, at least from the audience\u2019s response, should not be continued due to the risks of unpredictable viral rebound.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p>We also use this issue to highlight several posters from the conference covering changing comorbidities in a UK ageing cohort, use of digital (finger, not electronic) monitoring for HPV, high rates of HPV in a PrEP cohort, and high incidence of HCV reinfection (also in a PrEP cohort.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p>We include a review of cure-related studies, two studies about increasing access to viral load testing, and a UK protocol for helping diagnose people whose HIV test results are repeatedly indeterminate.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p>An additional report from the paediatric workshop reviews a new dispersible tablet formulation of dolutegravir for children.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p>Antiretroviral news includes top-line results from the phase 3 ATLAS study, bringing long-acting, injectable ART a little closer and new FDA updates on interactions between anticoagulants and Genvoya, Stribild and cobicistat.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p>We include sobering news on continued rates of death to drug overdoses, especially to opiates and recreational drugs.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p>And we end with new resources from the Martin Fisher Foundation that include online videos to reduce HIV-related stigma.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/date\/2018\/08\/24\">Contents online<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2018\/08\/HTB-24-Aug-2018-no-14-2-column.pdf\" rel=\"noopener\">PDF of this issue<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/forms\/esub.php\">Subscribe by email<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Contents online PDF of this issue Subscribe by email This issue of HTB continues our reports from the 22nd International AIDS Conference (AIDS 2018) that was held from 23\u201327 July 2018 in Amsterdam.\u00a0 We start with the optimistic news that &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-34879","post","type-post","status-publish","format-standard","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/34879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=34879"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/34879\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=34879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=34879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=34879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}